Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04129333
Other study ID # 35RC18_8853_HYPIC
Secondary ID 2019-A01775-52
Status Completed
Phase N/A
First received
Last updated
Start date December 30, 2019
Est. completion date October 11, 2022

Study information

Verified date November 2022
Source Rennes University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Procedural pain in resuscitation is common in the conscious patient. However, analgesia and sedation may be impossible because of the acute pathology leading to resuscitation, comorbidities or the urgency of the invasive procedure. In addition, the use of analgesics and sedatives is responsible for adverse effects. In this context, hypnosis appears to be an additional analgesic tool that would reduce the consumption of analgesics and sedatives and thus reduce their side effects.


Recruitment information / eligibility

Status Completed
Enrollment 80
Est. completion date October 11, 2022
Est. primary completion date January 25, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Major patient admitted to intensive care - Glasgow score = 15 - Necessity during the stay of making an invasive gesture among: - Thoracic drainage - Placement of a central venous catheter or a Swan-Ganz catheter - Establishment of a dialysis catheter - Introduction of an invasive arterial catheter - Patient giving free, informed and written consent - Patient affiliated to a social security scheme Non inclusion Criteria: - Procedure to be carried out in extreme urgency - Confusional state making hypnosis impossible, evaluated by CAM-ICU (Confusion Assessment Method for the Intensive Care Unit) - Decompensated psychiatric illness - Patient sedated or intravenous analgesia continued at the time of the procedure - Patient intubated - Patient with a contraindication to sedation or analgesia at the time of the procedure - Patient receiving topical anesthesia before the start of the procedure - Major person subject to legal protection (court bail, curator, guardianship) or deprived of liberty - Patient already included in the study during the completion of a previous invasive procedure - Patient participating in a research involving an interventional human person (category 1) on an analgesic / sedative drug

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Hypnosis
The hypnosis session : Creation of the therapist-patient link Choice of a theme and the preferred sensory channel by the patient Collection of the theme chosen by the patient Orientation in the here and now. Induction Realization of the gesture and hypnosis At the end of the procedure, reassociation of the patient in the here and now
No hypnosis
No hypnosis

Locations

Country Name City State
France Rennes University Hospital Rennes
France Saint-Brieuc Hospital Saint-Brieuc Bretagne

Sponsors (1)

Lead Sponsor Collaborator
Rennes University Hospital

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Pain assessment Oral assessment scale (0 : no pain - 10 : maximal pain) Immediately after the end of the invasive procedure (Hour 0)
Secondary Pain assessment Oral assessment scale (0 : no pain - 10 : maximal pain) The first hour after the end of the procedure (Hour 1)
Secondary Morphine equivalent dose Cumulative use of morphine-morphine analgesics in morphine equivalent during the procedure and the first hour after the end of the procedure (H1) Immediately after the end of the invasive procedure (H0) and the first hour after the end of the procedure (H1)
Secondary Sedatives dose Cumulative use of sedatives during the procedure and the first hour after the end of the procedure (H1) Immediately after the end of the invasive procedure (Hour 0) and the first hour after the end of the procedure (Hour 1)
Secondary Local Anesthesia dose Consumption of local anesthesia during the invasive procedure Immediately after the end of the invasive procedure (Hour 0)
Secondary Comfort scale Comfort measured by the numerical comfort scale (0 no comfort - 10 most comfortable situation imaginable) Immediately after the end of the invasive procedure (H0) and the first hour after the end of the procedure (H1)
Secondary Anxiety Patient anxiety measured by the numerical anxiety scale (0 no anxiety - 10 greatest anxiety imaginable) . Immediately after the end of the invasive procedure (Hour 0) and the first hour after the end of the procedure (Hour 1)
Secondary Duration Duration of the invasive procedure including the period of hypnosis Immediately after the end of the invasive procedure (Hour 0)
Secondary Number of attempts and failures of the procedure Number of attempts and failures of the procedure The first hour after the end of the procedure (Hour 1)
Secondary Adverse events Number of adverse events occurring during the procedure (hematoma, failure to pose, ...) The first hour after the end of the procedure (Hour 1)
Secondary Nurse stress Stress of the nurse in charge of the patient quantified by a numerical scale of evaluation (0 no stress - 10 greatest stress imaginable) Immediately after the end of the invasive procedure (Hour 0)
Secondary Length of stay in intensive care unit Length of stay in intensive care unit, measured until D28 Day 28
See also
  Status Clinical Trial Phase
Completed NCT04276506 - Effect of Information Given and Music on the Care of Patient Who Will Undergo Coronary Angiography N/A
Recruiting NCT04286438 - Bentracimab in Ticagrelor-treated Patients With Uncontrolled Bleeding or Requiring Urgent Surgery or Invasive Procedure Phase 3
Terminated NCT03150303 - Oral Anticoagulant Peri-procedural Management in Patients Undergoing an Oral Surgery, Implantology or Periodontology